RESUMO
A novel approach to the management of vitiligo is described using a combination of epidermal autografts transplanted into the depigmented areas and psoralen-ultraviolet-A (PUVA) therapy. Epidermal autografts can be obtained rapidly and in large numbers using a device that combines the synergistic effects of suction and heat on the skin. Subsequent exposure to PUVA therapy promotes spread of pigmentation out of the grafts resulting in even and complete pigmentation. In certain situations, the combination therapy appears to offer the potential for avoiding the disadvantages of both of the two treatments when they are used alone. This article presents our preliminary work in the development of the methodology for this combined approach.
Assuntos
Epiderme/transplante , Terapia PUVA , Vitiligo/tratamento farmacológico , Vitiligo/cirurgia , Terapia Combinada , Humanos , Pigmentação da Pele , Sucção , Transplante Autólogo/instrumentação , Transplante Autólogo/métodos , Vitiligo/patologiaAssuntos
Malformações Arteriovenosas/diagnóstico , Pelve/irrigação sanguínea , Ultrassonografia , Útero/irrigação sanguínea , Adolescente , Adulto , Idoso , Fístula Arteriovenosa/diagnóstico , Fístula Arteriovenosa/etiologia , Malformações Arteriovenosas/etiologia , Malformações Arteriovenosas/patologia , Diagnóstico Diferencial , Feminino , Humanos , Masculino , Menopausa , Pessoa de Meia-Idade , Paridade , Gravidez , Útero/patologiaAssuntos
Pulmão/anormalidades , Diagnóstico Pré-Natal/métodos , Ultrassonografia , Adulto , Feminino , Humanos , Masculino , GravidezRESUMO
Cerebral infiltration due to chronic lymphocytic leukemia is rare. Leukemic infiltration of the brain can be diagnosed by computed tomography, and the response to treatment can be monitored. Leukemic cerebral infiltrates may occur as areas of variable attenuation that usually enhance following intravenous contrast medium administration. They can be differentiated from areas of leukoencephalopathy related either to the disease or treatment with drugs by their characteristic locations contiguous with cortical or ependymal surfaces, or adjacent to shunt tubing.